TY - JOUR
T1 - Ghrelin as a Survival Hormone
AU - Mani, Bharath K.
AU - Zigman, Jeffrey M.
N1 - Funding Information:
This work was supported by the NIH ( R01DK103884 to J.M.Z.). The authors thank T. DiCesare for his help in creating the illustration for Figure 3 . They thank Drs Mike Brown, Joe Goldstein, and Mike Lutter for their impactful and insightful work and thoughts regarding the protective nature of the ghrelin system. They also acknowledge the many authors whose important and relevant publications could not be individually cited due to space limitations.
Publisher Copyright:
© 2017 Elsevier Ltd
PY - 2017/12
Y1 - 2017/12
N2 - Ghrelin administration induces food intake and body weight gain. Based on these actions, the ghrelin system was initially proposed as an antiobesity target. Subsequent studies using genetic mouse models have raised doubts about the role of the endogenous ghrelin system in mediating body weight homeostasis or obesity. However, this is not to say that the endogenous ghrelin system is not important metabolically or otherwise. Here we review an emerging concept in which the endogenous ghrelin system serves an essential function during extreme nutritional and psychological challenges to defend blood glucose, protect body weight, avoid exaggerated depression, and ultimately allow survival. The ghrelin system comprises three main components: ghrelin, the ghrelin receptor (the growth hormone secretagogue receptor), and ghrelin-O-acyltransferase (GOAT). Endogenous ghrelin is involved in food anticipatory and food reward behavior but may not play a conspicuous orexigenic role when food availability is plentiful or in diet-induced obese states. The ghrelin system is essential during certain nutritional and psychological challenges including caloric restriction, cachexia, and psychosocial stress, orchestrating changes in several metabolic processes and behaviors to promote survival. Activation of the ghrelin system could be a viable pharmacological approach to promote food intake and defend against hypoglycemia, body weight loss, depression/anxiety, and death during extreme nutritional and psychological challenges including severe caloric restriction, cachexia, and psychosocial stress.
AB - Ghrelin administration induces food intake and body weight gain. Based on these actions, the ghrelin system was initially proposed as an antiobesity target. Subsequent studies using genetic mouse models have raised doubts about the role of the endogenous ghrelin system in mediating body weight homeostasis or obesity. However, this is not to say that the endogenous ghrelin system is not important metabolically or otherwise. Here we review an emerging concept in which the endogenous ghrelin system serves an essential function during extreme nutritional and psychological challenges to defend blood glucose, protect body weight, avoid exaggerated depression, and ultimately allow survival. The ghrelin system comprises three main components: ghrelin, the ghrelin receptor (the growth hormone secretagogue receptor), and ghrelin-O-acyltransferase (GOAT). Endogenous ghrelin is involved in food anticipatory and food reward behavior but may not play a conspicuous orexigenic role when food availability is plentiful or in diet-induced obese states. The ghrelin system is essential during certain nutritional and psychological challenges including caloric restriction, cachexia, and psychosocial stress, orchestrating changes in several metabolic processes and behaviors to promote survival. Activation of the ghrelin system could be a viable pharmacological approach to promote food intake and defend against hypoglycemia, body weight loss, depression/anxiety, and death during extreme nutritional and psychological challenges including severe caloric restriction, cachexia, and psychosocial stress.
KW - blood glucose
KW - cachexia
KW - ghrelin
KW - hypoglycemia
KW - psychosocial stress
KW - survival
UR - http://www.scopus.com/inward/record.url?scp=85032729616&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85032729616&partnerID=8YFLogxK
U2 - 10.1016/j.tem.2017.10.001
DO - 10.1016/j.tem.2017.10.001
M3 - Review article
C2 - 29097101
AN - SCOPUS:85032729616
SN - 1043-2760
VL - 28
SP - 843
EP - 854
JO - Trends in Endocrinology and Metabolism
JF - Trends in Endocrinology and Metabolism
IS - 12
ER -